Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2021 > Vol 2, №7 (2021) > Hypoglycemia, an obstacle to achieving glycemic control. Importance of blood glucose self-monitoring

Hypoglycemia, an obstacle to achieving glycemic control. Importance of blood glucose self-monitoring

Inna V. Urlaeva

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Hypoglycemia is a well-known factor, limiting the patient's ability to achieve adequate glycemic control, and capable of causing a number of car-diovascular diseases (CVDs). Recurrent hypoglycemia may result in severe, potentially fatal complication of diabetes mellitus (DM), the impaired hypoglycemia awareness, raising the risk of severe hypoglycemia up up to six times. Measuring blood glucose levels is a universally accepted com-ponent of glycemic control and one of the strategies for prevention of hypoglycemia, along with the structured patient education in DM manage-ment and the use of modern hypoglycemic medications. Prevention of severe hypoglycemia may be important for prevention of CVDs in patients with DM. 

Kew words: diabetes mellitus, hypoglycemia, glucose meter, impaired awareness of hypoglycemia.

About the Author

Inna V. Urlaeva 1

1 Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russia

References

1. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in in-sulin-dependent diabetes mellitus. N Engl J Med 1993; 329 (14): 977–86. DOI: 10.1056/NEJM199309303291401
2. Ratzki-Leewing A, Harris SB, Mequanint S et al. Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the In-Hypo-DM Study, Canada. BMJ Open Diabetes Res Care 2018; 6 (1): e000503. DOI: 10.1136/bmjdrc-2017-000503
3. Cariou B, Fontaine P, Eschwege E et al. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 dia-betes mellitus patients in a real-life setting: results from the DIA-LOG study. Diabetes Metab 2015; 41 (2): 116–25. DOI: 10.1016/j.di-abet.2014.10.007
4. Malkani S, Kotwal A. Frequency and Predictors of Self-Reported Hypoglycemia in Insulin-Treated Diabetes. J Diabetes Res 2017; 2017: 7425925. DOI: 10.1155/2017/7425925
5. Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R et al. Hy-poglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Curr Diab Rep 2018; 18 (8): 53. DOI: 10.1007/s11892-018-1018-0
6. Misra-Hebert AD, Pantalone KM, Ji X et al. Patient Characteristics Associated With Severe Hypoglycemia in a Type 2 Diabetes Cohort in a Large, Integrated Health Care System From 2006 to 2015. Di-abetes Care 2018; 41 (6): 1164–71. DOI: 10.2337/dc17-1834
7. Standards of specialized diabetes care. Edited by I.I. Dedov, M.V. Shestakova, A.Yu. Mayorov. 9th Edition (revised). Moscow: UP PRINT, 2019. DOI: 10.14341/DM221S1 (in Russian).
8. Geddes J, Schopman JE, Zammitt NN, Frier BM. Prevalence of im-paired awareness of hypoglycaemia in adults with Type 1 diabetes. Diabet Med 2008; 25 (4): 501 4. DOI: 10.1111/j.1464-5491.2008. 02413.x 
9. UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007; 50 (6): 1140–7. DOI: 10.1007/s00125-007-0599-y 
10. Hwang JJ, Parikh L, Lacadie C et al. Hypoglycemia unawareness in type 1 diabetes suppresses brain responses to hypoglycemia. J Clin Invest 2018; 128 (4): 1485–95. DOI: 10.1172/JCI97696
11. Emerging Risk Factors Collaboration, Sarwar N, Gao P et al. Dia-betes mellitus, fasting blood glucose concentration, and risk of vas-cular disease: a collaborative meta-analysis of 102 prospective studies published correction appears in Lancet. 2010; 376 (9745):
958. Hillage HL [corrected to Hillege HL]]. Lancet 2010; 375 (9733): 2215–22. DOI: 10.1016/S0140-6736(10)60484-9
12. Rickels MR. Hypoglycemia-associated autonomic failure, counter-regulatory responses, and therapeutic options in type 1 diabetes. Ann N Y Acad Sci 2019; 1454 (1): 68–79. DOI: 10.1111/nyas.14214
13. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164 (13): 1422–
6. DOI: 10.1001/archinte.164.13.1422
14. Haffner SM, Lehto S, Rönnemaa T et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339 (4): 229–34. DOI: 10.1056/NEJM199807233390404
15. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002; 287 (19): 2570–81. DOI: 10.1001/jama.287.19.2570
16. Laing SP, Swerdlow AJ, Slater SD et al. Mortality from heart dis-ease in a cohort of 23,000 patients with insulin-treated diabetes. Di-abetologia 2003; 46 (6): 760–5. DOI: 10.1007/s00125-003-1116-6
17. Huang D, Refaat M, Mohammedi K et al. Macrovascular Complica-tions in Patients with Diabetes and Prediabetes. Biomed Res Int 2017; 2017: 7839101. DOI: 10.1155/2017/7839101 
18. Davis IC, Ahmadizadeh I, Randell J et al. Understanding the impact of hypoglycemia on the cardiovascular system. Expert Rev Endocrinol Metab 2017; 12 (1): 21–33. DOI: 10.1080/17446651. 2017.1275960
19. Sommerfield AJ, Wilkinson IB, Webb DJ, Frier BM. Vessel wall stiff-ness in type 1 diabetes and the central hemodynamic effects of acute hypoglycemia. Am J Physiol Endocrinol Metab 2007; 293 (5): E1274-E1279. DOI: 10.1152/ajpendo.00114.2007
20. Goto A, Arah OA, Goto M et al. Severe hypoglycaemia and cardio-vascular disease: systematic review and meta-analysis with bias analysis. BMJ 2013; 347: f4533. DOI: 10.1136/bmj.f4533
21. Miller KM, Beck RW, Bergenstal RM et al. Evidence of a strong as-sociation between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care 2013; 36 (7): 2009–14. DOI: 10.2337/dc12-1770
22. Schütt M, Kern W, Krause U et al. Is the frequency of self-monitor-ing of blood glucose related to long-term metabolic control? Multi-center analysis including 24,500 patients from 191 centers in Ger-many and Austria. Exp Clin Endocrinol Diabetes 2006; 114 (7): 384–8. DOI: 10.1055/s-2006-924152
23. Chrvala CA, Sherr D, Lipman RD. Diabetes self-management edu-cation for adults with type 2 diabetes mellitus: A systematic review of the effect on glycemic control. Patient Educ Couns 2016; 99 (6): 926–43. DOI: 10.1016/j.pec.2015.11.003
24. Mannucci E, Antenore A, Giorgino F, Scavini M. Effects of Struc-tured Versus Unstructured Self-Monitoring of Blood Glucose on Glu-cose Control in Patients With Non-insulin-treated Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. J Diabetes Sci Technol 2018; 12 (1): 183–9. DOI: 10.1177/1932296817719290
25. Downing J, Bollyky J, Schneider J. Use of a Connected Glucose Meter and Certified Diabetes Educator Coaching to Decrease the Likelihood of Abnormal Blood Glucose Excursions: The Livongo for Diabetes Pro-gram. J Med Internet Res 2017; 19 (7): e234. DOI: 10.2196/jmir.6659
26. Bailey T et al. Accuracy and User Performance Evaluation of a New, Wireless-enabled Blood Glucose Monitoring System That Links to a Smart Mobile Device. J Diabetes Sci Technol 2017; 11 (4): 736–43.

For citation:Hypoglycemia, an obstacle to achieving glycemic control. Importance of blood glucose self-monitoring. Clinical review for general practice. 2021; 7: 40–44. DOI: 10.47407/kr2021.2.7.00087


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru